dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
['lymphoma', 'brentuximab', 'leusm', 'nivo', 's1826', 'cml', ' vedo', 'nivolumab']
congress |#17icml
alex f herrera presented results from the swog s1826 trial of nivolumab(n)-avd vs brentuximab vedotin (bv)-avd in pts with advanced-stage hl. 1-year pfs was 94% vs 86% in n avd &amp; bv-avd, respectively with a manageable safety profile #lymphoma #leusm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm